Liver fibrosis initiation revisited
ID
MSCA-2020-LVGrunsven02
Supervisors
Project description
Liver fibrosis is the pathological condition of the liver resulting from sustained wound healing in response to various causes of liver injury, including chronic alcohol abuse, viral infections or obesity. Liver disease remains a global issue, with an estimated death toll of over 1.3 million deaths due to liver cirrhosis, the advanced form of liver fibrosis. Fibrosis, or scarring of the liver, constitutes the deposition of excessive amounts of extra-cellular matrix, which is produced mostly by hepatic stellate cells (HSCs) that upon liver damage switch from a quiescent state to an activated myofibroblastlike state. Although extensively investigated, the initiating events that trigger and orchestrate HSC activation are still not entirely understood. In this project we would create a detailed transcriptomic landscape of HSC activation in vitro and in vivo with a focus on the first 24 hours. To get insight into the chromatin landscape and dynamics of quiescent- and activated HSCs, ATAC- and ChIP- sequencing at the population level, and super-resolution microscopy at the single cell level will be carried out. Finally, newly developed in vitro liver fibrosis models will be used to validate the importance of key transcription factors and histone modifiers identified during liver injury-induced HSC activation in vitro.
About the research Group
Liver Cell Biology Research Group
In general, research projects at LIVR aim to better characterize the different liver cell types in healthy and pathological conditions, and to gain a better insight in the mechanisms of liver regeneration and the pathogenesis of liver fibrosis.
The LIVR team investigates:
- the mechanisms of liver fibrosis development and resolution
- the identification of hepatic stellate cell-specific biomarkers for liver fibrosis staging
- the generation of in vitro liver disease models
- iPSC derived liver cells for in vitro disease modeling
- the role for liver progenitor cells during liver regeneration
Long term objectives are:
- Contribute to the understanding of mechanisms involved in liver fibrosis
- Discover therapeutic targets for chronic liver diseases including non-alcoholic fatty liver disease (NAFLD).
- Develop in vitro models representative for human chronic liver disease